On Air Now

Tune in to Listen

99.9 FM Hibbing, MN

Weather

Current Conditions(Hibbing,MN 55746)

More Weather »
74° Feels Like: 74°
Wind: S 8 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Partly Cloudy 51°

Tomorrow

Cloudy 66°

Wed Night

Clouds Early/Clearing Late 51°

Alerts

  • 0 Severe Weather Alerts
  • 0 Cancellations

UCB says U.S. FDA committee recommends its drug Cimzia for new uses

BRUSSELS (Reuters) - Belgian pharmaceutical group UCB SA said a committee of the U.S. Food and Drug Administration voted in favor of allowing UCB's arthritis drug Cimzia to be used to treat adults with active axial spondyloarthritis.

While the vote was not binding on a final recommendation, it would play a part in the decision to clear the drug for this application in the United States, UCB said.

Axial spondyloarthritis is an inflammatory disease mostly affecting the spine and the pelvis.

(Reporting by Robert-Jan Bartunek; Editing by Matt Driskill)

Comments